Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...

The makers of two popular weight-loss drugs—Wegovy and Zepbound—are cutting prices to make the medications more affordable ...

After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

The offer may show employers how hard drug manufacturers will compete based on price, in at least some situations.

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

The pharmaceutical giant markets the drug as Wegovy for people with obesity, and Ozempic for those with Type 2 diabetes alone or with heart or chronic kidney disease. The ad was a response to a ...

In addition to Wegovy, incretin mimetics FDA-approved for chronic weight management include Saxenda (liraglutide), also made by Novo Nordisk, and Zepbound (tirzepatide), produced by Fortune 500 ...

Are you a print subscriber? Activate your account. By Tim Nudd - 3 hours 55 min ago By Brian Bonilla - 4 hours 9 min ago By Tim Nudd - 9 hours 25 min ago 9 hours 55 min ago By Gillian Follett - 9 ...

Novo Nordisk, the Fortune 500 Europe company behind weight-loss injection Wegovy (semaglutide), responded Monday with a print ad of its own. “Do you really know what you’re injecting into your body?” ...

After telehealth brand Hims & Hers aired its first Super Bowl commercial Sunday night, competitor Novo Nordisk, which makes competing weight loss drugs Ozempic and Wegovy, responded with its own ...

These drugs use the same active ingredients, but Ozempic and Wegovy maker Novo Nordisk claimed this process put patients at risk. However, this also allowed pharmacies to offer these drugs at ...